Wyeth’s One-Two Allergy Punch: Advil Allergy Sinus To Join Alavert
This article was originally published in The Tan Sheet
Executive Summary
Wyeth Consumer Healthcare received FDA approval for its Advil Allergy Sinus on Dec. 19, the same day it received the agency go-ahead to market its non-sedating antihistamine Alavert
You may also be interested in...
Claritin, Alavert, Advil Allergy Sinus Head Major OTC Approvals In 2002
Antihistamines accounted for the most prominent OTC approvals in 2002, with Schering-Plough Healthcare Products' Claritin franchise and Wyeth Consumer Healthcare's Alavert and Advil Allergy Sinus all receiving the FDA go-ahead during the year
Claritin, Alavert, Advil Allergy Sinus Head Major OTC Approvals In 2002
Antihistamines accounted for the most prominent OTC approvals in 2002, with Schering-Plough Healthcare Products' Claritin franchise and Wyeth Consumer Healthcare's Alavert and Advil Allergy Sinus all receiving the FDA go-ahead during the year
Claritin, Alavert, Advil Allergy Sinus Head Major OTC Approvals In 2002
Antihistamines accounted for the most prominent OTC approvals in 2002, with Schering-Plough Healthcare Products' Claritin franchise and Wyeth Consumer Healthcare's Alavert and Advil Allergy Sinus all receiving the FDA go-ahead during the year